Clinical study to evaluate the effect of medicated Arka in Primary dysmenorrhea
Phase 2
- Conditions
- Health Condition 1: N944- Primary dysmenorrhea
- Registration Number
- CTRI/2022/11/047213
- Lead Sponsor
- Dr ASWINI S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients fulfilling the diagnostic criteria.
2.Age between 16-35 years
3.Painful menstruation for at least previous 2 consecutive cycles,
4.Patients with regular menstrual cycles.
5.Patient willing to sign the written consent
Exclusion Criteria
1.Cases of Secondary dysmenorrhoea with underlying pelvic pathology diagnosed by USG like Pelvic inflammatory disease, fibroids, endometriosis.
2.Patient with intrauterine contraceptive devices
3.Patientâ??s on hormonal therapy
4.Patient with gastritis
5.Known case of HIV, HBsAg, VDRL.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To see the reduction in the insensitive of pain <br/ ><br>and associated symptomsTimepoint: On completion of 2nd cycles and 3rd cycle
- Secondary Outcome Measures
Name Time Method nilTimepoint: nil